BioSpace News Archive

AstraZeneca to Leverage ArcherDX’s PCM Liquid Biopsy Technology to Facilitate Multiple Clinical Trials for Early-Stage Non-Small Cell Lung Cancer Therapies

Medivir AB announced that its Board of Directors has appointed Yilmaz Mahshid as the new CEO of the company.

Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities and Leica Biosystems, a global leader in workflow solutions and automation, are proud to announce the European launch of the CE-IVD marked RNAscope™ In Situ Hybridization Detection Kit for automation on the BOND-III platform.

Debiopharm announces successful exit deal for Kaiku Health, a Finnish start-up specializing in digital solutions for improved patient outcomes and experience

Transparency Market Research has published a new report titled, ‘Chromoendoscopy Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global chromoendoscopy agents market was valued at US$ 108.9 Mn in 2017 and is projected to expand at a CAGR of 3.4% from 2018 to 2026.

Transparency Market Research has published a new report titled “Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” According to the report, the global cardiac biomarker diagnostic kits market was valued at US$ 2,100 Bn in 2017.

TeraRecon, the market leader in Advanced Visualization and Artificial Intelligence solutions for medical imaging, welcomes two new members to its executive team.

OraSure Technologies, Inc., a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, announced that Dr. Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the Jefferies 2020 Healthcare Conference.

Mesoblast Limited, global leader in cellular medicines for inflammatory diseases, will host an analyst call to discuss the financial results for the period ended March 31, 2020.

Exact Sciences Corp. announced that company management will participate in the following conferences and invited investors to participate by webcast.